Ultrahypofractionation and Normal Tissue Toxicity

Clinical trial NCT05912231 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05912231
Sponsor: Massachusetts General Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Cancer Breast Cancer Female Breast Cancer Stage II Breast Cancer Stage III Myocardial Fibrosis

Start date: 2023-08-15
Primary completion: 2026-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.